Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SOND›
Analysis
AddedJun 25, 2026
UpdatedJun 25, 2026
SOND

SOND

Seed

SOND builds AI-powered sleep earbuds that sense physiological signals and respond in real time to improve sleep.

HQ
Boston, MA, US
Founded
2022
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website
Number of Customers
1,000

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

Dreambuds are SOND's flagship in-ear sleep system designed to sense the body overnight and respond in real time. They capture twelve physiological signals—including respiration, heart rate variability, sleep staging, body position, snoring, and seismocardiography—and stream the data to a cloud-based AI sleep coach.

The coach selects from a library of more than 500 audio programs or generates personalized content such as breathing exercises, soundscapes, and sleep stories. The earbuds work phone-free through a Wi-Fi-enabled charging case with an OLED display, physical controls, and a built-in speaker.

Market Outlook

The sleep technology market has been dominated by passive solutions such as white noise machines, basic sleep trackers, and noise-masking earbuds. SOND is positioning Dreambuds as a next-generation device that moves the category from monitoring to real-time, personalized intervention.

If the company can deliver on comfort, battery life, and clinical-grade sensing in a consumer form factor, Dreambuds could set a new expectation for sleep wearables. The product is currently available by reservation, with mass production targeted for late 2026.

Competitive Advantages

SOND differentiates Dreambuds from passive sleep trackers and noise-masking earbuds by closing the loop between sensing and intervention. While competitors typically block noise or report morning sleep scores, Dreambuds adjust audio in real time based on live physiological signals.

The founding team combines deep experience from Bose's consumer sleep business and Google's engineering organization, plus MIT biosensor research. Scientific advisors from Harvard Medical School and UT Dallas lend clinical credibility to the platform.